Skip to main content

Publisher: Routledge, part of the Taylor & Francis Group

More about this publication?
Volume 18, Number 2, 1 July 2011

Introduction: Economics of the Pharmaceutical Industry: Essays in Honor of Henry G. Grabowski
pp. 149-150(2)
Authors: Mullins, C. Daniel; Vernon, John A.

Favourites:
ADD

An Overview of Henry Grabowski’s Scholarly Contributions
pp. 151-154(4)
Author: Berndt, Ernst R.

Favourites:
ADD

Academic Research and Public Policy
pp. 155-160(6)
Author: Scherer, F.M.

Favourites:
ADD

Diffusion of New Drugs in the Post-TRIPS Era
pp. 203-224(22)
Authors: Berndt, Ernst R.; Blalock, Nathan; Cockburn, Iain M.

Favourites:
ADD

Real Option Value and Path Dependence in Oncology Innovation
pp. 225-238(14)
Authors: Cook, Joseph P.; Golec, Joseph H.; Vernon, John A.; Pink, George H.

Favourites:
ADD

Vaccine Supply: Effects of Regulation and Competition
pp. 239-271(33)
Authors: Danzon, Patricia M.; Sousa Pereira, Nuno

Favourites:
ADD

Labor Prices and the Treatment of Nursing Home Residents with Dementia
pp. 273-292(20)
Authors: Grabowski, David C.; Bowblis, John R.; Lucas, Judith A.; Crystal, Stephen

Favourites:
ADD

Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
pp. 293-316(24)
Author: Lichtenberg, Frank R.

Favourites:
ADD

How Do US Health Care Payers React to and Use Pharmacoeconomic Information?
pp. 317-330(14)
Authors: Mullins, C. Daniel; Ratner, Jonathan; Ball, Daniel E.

Favourites:
ADD

Incentives for R&D for New Antimicrobial Drugs
pp. 331-350(20)
Authors: Towse, Adrian; Sharma, Priya

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more